Efficacy and Safety Study in Subjects With Asthma

Exclusion Criteria

• •History of Life-Threatening Asthma
• •No use of systemic corticosteroids for any indication within 8 weeks prior to Visit
• •No concurrent diseases/abnormalities that would put the safety of the subject at risk through study participation
• •Drug Allergy to β2 agonist or sympathomimetic drugs, or known or suspected sensitivity to lactose or magnesium stearate
• •History of severe milk protein allergy
• •Non-compliance with study medication and other study-related requirements
• •No use of inhaled tobacco products within the past three months or historical use of 10 pack years or more
• •Administration of prohibited medications and non-drug therapies and corresponding timeframes as outlined in the protocol